Back to search

Article

Physical Activity Improves Outcomes of Combined Lenvatinib Plus Anti-PD-1 Therapy In Patients With Unresectable Hepatocellular Carcinoma

2021-11-19

Abstract excerpt

<title>Abstract</title> <p><bold>Background: </bold>Adaptive resistance is one of the major hinderances for unresectable hepatocellular carcinoma (HCC)<bold> </bold>treated<bold> </bold>with lenvatinib and<bold> </bold>anti-programmed cell death protein 1 (anti-PD-1) therapy. Physical activity is known to have anti-cancer effects, including immunomodulatory actions, influencing patients’ outcomes. This study inve...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
503a44f2-8d21-5ffb-8f8f-29be3a95a432
DOI
10.21203/rs.3.rs-1078571/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Physical Activity Improves Outcomes of Combined Lenvatinib Plus Anti-PD-1 Therapy In Patients With Unresectable Hepatocellular CarcinomaDOI 10.21203/rs.3.rs-1078571/v1
Select a neighboring publication to make it the new centre.